Literature DB >> 29667122

The gene-editing of super-ego.

Bjørn Hofmann1,2.   

Abstract

New emerging biotechnologies, such as gene editing, vastly extend our ability to alter the human being. This comes together with strong aspirations to improve humans not only physically, but also mentally, morally, and socially. These conjoined ambitions aggregate to what can be labelled "the gene editing of super-ego." This article investigates a general way used to argue for new biotechnologies, such as gene-editing: if it is safe and efficacious to implement technology X for the purpose of a common good Y, why should we not do so? This is a rhetorical question with a conditional, and may be dismissed as such. Moreover, investigating the question transformed into a formal argument reveals that the argument does not hold either. Nonetheless, the compelling force of the question calls for closer scrutiny, revealing that this way of arguing for biotechnology is based on five assumptions. Analysis of these assumptions shows their significant axiological, empirical, and philosophical challenges. This makes it reasonable to claim that these kinds of question based promotions of specific biotechnologies fail. Hence, the aspirations to make a super-man with a super-ego appear fundamentally flawed. As these types of moral bioenhancement arguments become more prevalent, a revealing hype test is suggested: What is special with this technology (e.g., gene editing), compared to existing methods, that makes it successful in improving human social characteristics in order to make the world a better place for all? Valid answers to this question will provide good reasons to pursue such technologies. Hence, the aim is not to bar the development of modern biotechnology, but rather to ensure good developments and applications of highly potent technologies. So far, we still have a long way to go to make persons with goodness gene(s).

Entities:  

Keywords:  Crispr; Enhancement; Gene-editing; Social biology; Super-ego

Mesh:

Year:  2018        PMID: 29667122     DOI: 10.1007/s11019-018-9836-z

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  20 in total

1.  Is there a technological imperative in health care?

Authors:  Bjørn Hofmann
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

2.  Genomics is not enough.

Authors:  Aravinda Chakravarti
Journal:  Science       Date:  2011-10-07       Impact factor: 47.728

Review 3.  Characterization of noncoding regulatory DNA in the human genome.

Authors:  Ran Elkon; Reuven Agami
Journal:  Nat Biotechnol       Date:  2017-08-08       Impact factor: 54.908

4.  Modeling the Social Dynamics of Moral Enhancement: Social Strategies Sold Over the Counter and the Stability of Society.

Authors:  Anders Sandberg; Joao Fabiano
Journal:  Camb Q Healthc Ethics       Date:  2017-07       Impact factor: 1.284

5.  Should moral bioenhancement be compulsory? Reply to Vojin Rakic.

Authors:  Ingmar Persson; Julian Savulescu
Journal:  J Med Ethics       Date:  2013-03-22       Impact factor: 2.903

6.  Bright New World.

Authors:  Ole Martin Moen
Journal:  Camb Q Healthc Ethics       Date:  2016-04       Impact factor: 1.284

7.  Genes underlying altruism.

Authors:  Graham J Thompson; Peter L Hurd; Bernard J Crespi
Journal:  Biol Lett       Date:  2013-10-16       Impact factor: 3.703

8.  Moral enhancement and freedom.

Authors:  John Harris
Journal:  Bioethics       Date:  2010-12-07       Impact factor: 1.898

9.  Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence.

Authors:  Suzanne Sniekers; Sven Stringer; Kyoko Watanabe; Philip R Jansen; Jonathan R I Coleman; Eva Krapohl; Erdogan Taskesen; Anke R Hammerschlag; Aysu Okbay; Delilah Zabaneh; Najaf Amin; Gerome Breen; David Cesarini; Christopher F Chabris; William G Iacono; M Arfan Ikram; Magnus Johannesson; Philipp Koellinger; James J Lee; Patrik K E Magnusson; Matt McGue; Mike B Miller; William E R Ollier; Antony Payton; Neil Pendleton; Robert Plomin; Cornelius A Rietveld; Henning Tiemeier; Cornelia M van Duijn; Danielle Posthuma
Journal:  Nat Genet       Date:  2017-05-22       Impact factor: 38.330

Review 10.  Limits to human enhancement: nature, disease, therapy or betterment?

Authors:  Bjørn Hofmann
Journal:  BMC Med Ethics       Date:  2017-10-10       Impact factor: 2.652

View more
  2 in total

1.  Science fiction and bioethics.

Authors:  Bert Gordijn; Henk Ten Have
Journal:  Med Health Care Philos       Date:  2018-09

Review 2.  Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application.

Authors:  Sikandar Hayat Khan
Journal:  Mol Ther Nucleic Acids       Date:  2019-04-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.